Cargando…

The influence of thionamides on intra-thyroidal uptake of (131)I during radioiodine-131 treatment of Graves’ disease

Graves’ disease is one of the most common causes of hyperthyroidism. Guideline recommendations advocate the intake of thionamides for at least 1 year. If hyperthyroidism persists, subsequent radioiodine-131 treatment (RIT) is a therapeutic option. Thionamides are known to influence intra-thyroidal b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Happel, Christian, Bockisch, Benjamin, Leonhäuser, Britta, Sabet, Amir, Grünwald, Frank, Groener, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692093/ https://www.ncbi.nlm.nih.gov/pubmed/38040820 http://dx.doi.org/10.1038/s41598-023-47228-z

Ejemplares similares

The influence of thyroid hormone medication on intra-therapeutic half-life of (131)I during radioiodine therapy of solitary toxic thyroid nodules
por: Happel, Christian, et al.
Publicado: (2022)

Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of (131)I during radioiodine therapy of Graves’ disease
por: Happel, C., et al.
Publicado: (2021)

Analysis of risk factors of rapid thyroidal radioiodine-131 turnover in Graves’ disease patients
por: Zhang, Ruiguo, et al.
Publicado: (2017)

A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

Primary autoimmune thrombocytopenia and co-existing Graves’ disease: Role of radioiodine-131
por: Jung, Rayamajhi Sampanna, et al.
Publicado: (2014)

Retrospective Analysis of the Development of Human Thyroglobulin during Pregnancy in Patients with Treated Non-Recurrent Differentiated Thyroid Cancer
por: Baumgarten, Justus, et al.
Publicado: (2022)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Disorders of Dental Hard Tissues Induced by Radioiodine-131 (I-131) Therapy Used in Differentiated Thyroid Cancer: An In Vitro Study
por: Mester, Alexandru, et al.
Publicado: (2020)

Radiosensitive effect of curcumin on thyroid cancer cell death induced by radioiodine-131
por: Hosseinimehr, Seyed Jalal, et al.
Publicado: (2014)

Apoptosis gene reprograming of human peripheral blood mononuclear cells induced by radioiodine-131 ((131)I) irradiation
por: Li, Jian-Fang, et al.
Publicado: (2019)

Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer
por: Gao, Haiyan, et al.
Publicado: (2023)

Prediction of thyroidal (131)I effective half-life in patients with Graves' disease
por: Zhang, Ruiguo, et al.
Publicado: (2017)

Predictive value of pyramidal lobe, percentage thyroid uptake and age for ablation outcome after 15 mCi fixed dose of radioiodine-131 in Graves’ disease
por: Zaman, Maseeh uz, et al.
Publicado: (2015)

The false-positive radioiodine I-131 uptake in the foreign body granuloma located in gluteal adipose tissue
por: Gültekin, Salih Sinan, et al.
Publicado: (2011)

Treatment failure in hyperthyroid cats after radioiodine (I‐131) injection
por: Mullowney, Deirdre, et al.
Publicado: (2021)

Heat sink effects in thyroid bipolar radiofrequency ablation: an ex vivo study
por: Klimek, Konrad, et al.
Publicado: (2023)

Improving (131)I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nanoparticles
por: Le Goas, Marine, et al.
Publicado: (2019)

Autonomous Functioning Thyroid Nodule in a 4-year-old Male Child Treated with Radioiodine (I-131)
por: Khare, Abhishek, et al.
Publicado: (2013)

Lithium as an alternative option in thionamide-resistant Graves’ disease
por: Chung, Ying Ki, et al.
Publicado: (2023)

I-131 uptake in fat necrosis of the breast
por: Itani, Malak, et al.
Publicado: (2016)

SUN-510 Prolonged RAIA Induced Thyroiditis After 131 I Therapy for Graves’ Hyperthyroidism
por: Aljaberi, Asma Khaled, et al.
Publicado: (2020)

Impact of thyroiditis on (131)I uptake during ablative therapy for differentiated thyroid cancer
por: Lim, Eugenie S, et al.
Publicado: (2019)

Effects of drugs on the efficacy of radioiodine ((131)|) therapy in hyperthyroid patients
por: Oszukowska, Lidia, et al.
Publicado: (2010)

Development of [(131)I]I-EOE-TPZ and [(131)I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia
por: Elsaidi, Hassan, et al.
Publicado: (2019)

Transcriptional response to (131)I exposure of rat thyroid gland
por: Rudqvist, Nils, et al.
Publicado: (2017)

Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma
por: Oral, Aylin, et al.
Publicado: (2018)

Adverse Reactions to Radioiodine 131I Therapy of Goiter in West African Tertiary Hospital
por: Onimode, Yetunde A., et al.
Publicado: (2016)

Predictors of euthyreosis in hyperthyroid patients treated with radioiodine (131)I(−): a retrospective study
por: Stachura, Albert, et al.
Publicado: (2020)

The Thionamide Paradox: Thyrotoxicosis With Neutropenia as Initial Presentation of Grave’s Disease
por: Celis, Valentina, et al.
Publicado: (2021)

MON-437 False Positive I-131 Uptake
por: Yadav, Pavan Rajendra, et al.
Publicado: (2020)

Unusual Sites of Metastatic and Benign I 131 Uptake in Patients with Differentiated Thyroid Carcinoma
por: Palaniswamy, Shanmuga S., et al.
Publicado: (2018)

Thyroid papillary cancer elements arising from struma ovarii with benign peritoneal strumosis: Utility of iodine‐123 imaging in diagnostics and treatment planning
por: Groener, Daniel, et al.
Publicado: (2023)

Ultrasonography Echotexture as a surrogate for Sialadenitis secondary to 131I Radioiodine Therapy for differentiated Thyroid Cancer: a review and metaanalysis
por: Lima, Graziele Aparecida Simões, et al.
Publicado: (2020)

Thyroid Cancer after Exposure to Radioiodine in Childhood and Adolescence: (131)I-Related Risk and the Role of Selected Host and Environmental Factors
por: Zupunski, Ljubica, et al.
Publicado: (2019)

MON-443 SPECT/CT Localization of Incidental Diverticular Bleed After Radioiodine (i(131)) Therapy for Metastatic Thyroid Cancer
por: Doshi, Sejal B, et al.
Publicado: (2020)

Outpatient (131)I Treatment for a Patient with Graves' Disease Receiving Hemodialysis
por: Suzuki, Miho, et al.
Publicado: (2016)

A case report of (131)I therapy for Graves’ disease patient with hemiagenesis
por: Liu, Xuehui, et al.
Publicado: (2019)

Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014)

Induction of Leukaemia by (131)I Treatment of Thyroid Carcinoma
por: Brincker, H., et al.
Publicado: (1973)

Cannot write session to /tmp/vufind_sessions/sess_au20e9qirtgi384jek6pka5du6